E Holz
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Immunotherapy and Immune Responses 2
-
- Monoclonal and Polyclonal Antibodies Research 3
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- Rudolf Gruber (3 shared papers)G. Riethmüller (4 shared papers)R. Raab (2 shared papers)Günter Schlimok (1 shared paper)K. Höffken (1 shared paper)I. Funke (1 shared paper)H. Hirche (1 shared paper)Peter Buggisch (1 shared paper)
- Journals
- Recent results in cancer research (2 papers)Journal of Clinical Oncology (1 paper)Advances in Therapy (1 paper)PubMed (2 papers)Clinical Immunotherapeutics (1 paper)
- Partner nations
- GermanySwitzerlandBulgaria
In The Last Decade
E Holz
8 papers receiving 476 citations
Peers
Comparison fields: 5 of 49
- Oncology 253
- Radiology, Nuclear Medicine and Imaging 179
- Immunology 170
- Biotechnology 33
- Pathology and Forensic Medicine 56
Countries citing papers authored by E Holz
This map shows the geographic impact of E Holz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Holz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Holz more than expected).
Fields of papers citing papers by E Holz
This network shows the impact of papers produced by E Holz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Holz. The network helps show where E Holz may publish in the future.
Co-authors
The 17 scholars most cited alongside E Holz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 427 | |
| 2 | The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A. | 2000 | 42 |
| 3 | 1996 | 10 | |
| 4 | 1996 | 9 | |
| 5 | 1998 | 4 | |
| 6 | 1996 | 3 | |
| 7 | Experimental allergic myocarditis. | 2008 | 3 |
| 8 | 2025 | 1 |
About E Holz
E Holz is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology and Genetics, having authored 8 papers that have together received 499 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), Immunotherapy and Immune Responses (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Glycosylation and Glycoproteins Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Oncology (253 citations), Radiology, Nuclear Medicine and Imaging (179 citations), Immunology (170 citations), Biotechnology (33 citations) and Pathology and Forensic Medicine (56 citations). E Holz has collaborated with scholars based in Germany, Switzerland and Bulgaria. Frequent co-authors include Rudolf Gruber, G. Riethmüller, R. Raab, Günter Schlimok, K. Höffken, I. Funke, H. Hirche, Peter Buggisch, Wolff Schmiegel and H. Pichlmaier. Their work appears in journals such as Recent results in cancer research, Journal of Clinical Oncology, Advances in Therapy, PubMed and Clinical Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.